futurechem fc303 prostate
Scope
Date
~
-
Bio & Pharma
JLK gets FDA OK for prostate cancer diagnosis AI solution
South Korea’s JLK Inc., an AI-based diagnosis solution and platform maker, announced on Monday that it got approval from the US Food and Drug ...
Jun 25, 2024 (Gmt+09:00)
-
Food & Beverage
Oil from S.Korea’s red ginseng alleviates prostate enlargement: study
Oil from South Korea’s famous hongsam (red ginseng) can prevent enlargement of the prostate, according to a study. A joint research team ...
Mar 22, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's FutureChem gets approval for phase 3 clinical trials in China
South Korean radiopharmaceutical development company FutureChem Co. announced on Thursday that China's National Medical Products Administration (NMP...
Mar 17, 2023 (Gmt+09:00)
-
Bio & Pharma
FutureChem seeks FDA nod for prostate cancer radiopharma trials
FutureChem Co., a South Korean radiopharmaceutical company, is seeking the US Food and Drug Administration’s approval for clinical tests of it...
Apr 20, 2022 (Gmt+09:00)
Latest News
- 1 BYD’s Atto 3 overtakes Tesla’s Model Y as best-selling EV in South Korea
- 2 Korea’s top cinema chains seek merger to counter box office slump
- 3 S.Korea’s GEPS to commit $143 million to foreign mid-cap buyout funds
- 4 CJ CheilJedang to open $72 mn dumpling plant in Japan
- 5 LG Electronics breaks ground on $600 million home appliance plant in India